BERACTANT is a lung surfactant. Our bodies need lung surfactant to keep the lungs open during breathing. This medicine is used to prevent and to treat Respiratory Distress Syndrome (RDS) in babies who are born early.
Beractant, also known by the trade name of Survanta, is a modified bovine
pulmonary surfactant containing bovine lung extract to which synthetic DPPC, ...
Physician reviewed beractant patient information - includes beractant description,
dosage and directions.
Learn about SURVANTA® (beractant) dosing, administration, safety and efficacy
for prevention and treatment of respiratory distress syndrome (RDS)
SURVANTA ® (beractant) Intratracheal Suspension is a sterile, non-pyrogenic
pulmonary surfactant intended for intratracheal use only. It is a natural bovine ...
Apr 25, 2013 ... Learn about indications, dosage and how it is supplied for the drug Survanta (
Pictures of Survanta (Beractant), drug imprint information, side effects for the
Medscape - Indication-specific dosing for Survanta (beractant), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Consumer Medicine Information (CMI) about Survanta (beractant) intended for
persons living in Australia.
NOTE: Beractant is indicated for prevention and treatment (“rescue”) of
Respiratory Distress Syndrome (RDS) in premature infants. In premature infants
less than ...